ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Period	TotalRevenue
2015-12-31	$20.60M
2016-12-31	$4.21M
2017-12-31	$9.87M
2018-12-31	$13.13M
2019-12-31	$9.88M
2020-12-31	$14.51M
2021-12-31	$79.04M
2022-12-31	$122.65M
2023-12-31	$34.98M
2024-12-31	$6.77M

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRPH	$0.08	-10.89%	0.03M
3
4
5

ProPhase Labs Inc. (PRPH) Revenue History

Revenue Data

Get ProPhase Labs Inc. Data in Excel

More PRPH Financial Data